Prognostic role of brachial reactivity in patients with ST myocardial infarction after percutaneous coronary intervention
Authors:
- 1 November 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Coronary Artery Disease
- Vol. 20 (7) , 467-472
Abstract
Objective We hypothesized that flow-mediated vasodilation (FMD) in the brachial artery as a noninvasive method is of value in providing further predictive insights in a cohort of patients with ST-segment elevation acute myocardial infarction (STEMI) after percutaneous coronary intervention (PCI). Methods and results One hundred and one patients (62.43±9.06, 67 men) with STEMI, undergoing successful primary and rescue PCI, were included in this study. FMDs of all patients were determined using ultrasound after PCI. Patients were tracked for subsequent cardiovascular events. Twenty-nine patients had an event during 12.1±2.6 months of follow-up. Multivariate Cox proportional hazard analysis identified a diagnosis of diabetes [hazard ratio (HR): 2.934, 95% confidence interval (CI): 1.314−6.548, P=0.0086], ejection fraction (HR: 0.900, 95% CI: 0.832−0.973, P=0.0082), and FMD (HR: 0.705, 95% CI: 0.573−0.868, P=0.0010) after adjustment of all entered baseline variables. ROC analysis showed that FMD (ROC area: 0.689, P=0.0012; optimal threshold: 5.5% or less) had predictive value with sensitivity of 64%, specificity of 61%, positive predictive value of 40%, and negative predictive value of 81%. Conclusion In patients with STEMI, early evaluation of endothelial function after PCI could help to shed light on the mechanisms that increase the risk of new events. FMD could be used as a surrogate marker of events.Keywords
This publication has 28 references indexed in Scilit:
- Increased circulating C-reactive protein and macrophage-colony stimulating factor are complementary predictors of long-term outcome in patients with chronic coronary artery diseaseEuropean Heart Journal, 2005
- Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension*Journal Of Hypertension, 2005
- Endothelial Function Testing as a Biomarker of Vascular DiseaseCirculation, 2003
- Clinical Utility of Endothelial Function TestingCirculation, 2003
- Heads and HeartsCirculation, 2003
- Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial arteryJACC, 2002
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosisThe Lancet, 1992
- Serum Cholesterol, Blood Pressure, Cigarette Smoking, and Death From Coronary Heart Disease Overall Findings and Differences by Age for 316099 White MenArchives of internal medicine (1960), 1992
- Cholesterol and MortalityJAMA, 1987